{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T02:38:34Z","timestamp":1769740714404,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,25]],"date-time":"2017-02-25T00:00:00Z","timestamp":1487980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.vaccine.2017.02.048","type":"journal-article","created":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T13:31:12Z","timestamp":1489584672000},"page":"2084-2091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Bacille Calmette-Gu\u00e9rin (BCG) vaccination at birth and antibody responses to childhood vaccines. A randomised clinical trial"],"prefix":"10.1016","volume":"35","author":[{"given":"Thomas N\u00f8rrelykke","family":"Nissen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina Marie","family":"Birk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaby","family":"Smits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorthe Lisbeth","family":"Jeppesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lone Graff","family":"Stensballe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihai G.","family":"Netea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"van der Klis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine Stabell","family":"Benn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole","family":"Pryds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Kj\u00e6rgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisbeth Marianne","family":"Th\u00f8stesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gitte Thybo","family":"Pihl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poul-Erik","family":"Kofoed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Aaby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2017.02.048_b0005","doi-asserted-by":"crossref","first-page":"e1002607","DOI":"10.1371\/journal.ppat.1002607","article-title":"Vaccines against tuberculosis: where are we and where do we need to go?","volume":"8","author":"Ottenhoff","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2017.02.048_b0010","unstructured":"Barker LF, Hussey G. The immunological basis for immunization series\u202f: module 5: tuberculosis. World Heal Orig [Internet] 2011; Available from: <http:\/\/apps.who.int\/iris\/bitstream\/10665\/44733\/1\/9789241502412_eng.pdf>."},{"issue":"9517","key":"10.1016\/j.vaccine.2017.02.048_b0015","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.vaccine.2017.02.048_b0020","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1016\/j.vaccine.2005.12.044","article-title":"Protective effect of Bacillus Calmette-Guerin (BCG) vaccination in children with extra-pulmonary tuberculosis, but not the pulmonary disease. A case-control study in Rosario, Argentina","volume":"24","author":"Bonifachich","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2017.02.048_b0025","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/INF.0b013e3182458289","article-title":"Small randomized trial among low-birth-weight children receiving bacillus Calmette-Gu\u00e9rin vaccination at first health center contact","volume":"31","author":"Biering-S\u00f8rensen","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2017.02.048_b0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/infdis\/jir240","article-title":"Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?","volume":"204","author":"Aaby","year":"2011","journal-title":"J Infect Dis"},{"issue":"7274","key":"10.1016\/j.vaccine.2017.02.048_b0035","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1136\/bmj.321.7274.1435","article-title":"Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa","volume":"321","author":"Kristensen","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2017.02.048_b0040","doi-asserted-by":"crossref","first-page":"i5170","DOI":"10.1136\/bmj.i5170","article-title":"Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review","author":"Higgins","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.vaccine.2017.02.048_b0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2222.2007.02859.x","article-title":"Bacille-Calmette-Guerin vaccination and the development of allergic disease in children: a randomized, prospective, single-blind study","volume":"38","author":"Steenhuis","year":"2008","journal-title":"Clin Exp Allergy"},{"issue":"11","key":"10.1016\/j.vaccine.2017.02.048_b0050","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/cid\/civ144","article-title":"Nonspecific (heterologous) protection of neonatal BCG vaccination against hospitalization due to respiratory infection and sepsis","volume":"60","author":"de Castro","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2017.02.048_b0055","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1542\/peds.2013-2218","article-title":"Acute lower respiratory infection among Bacille Calmette-Guerin (BCG)-vaccinated children","volume":"133","author":"Hollm-Delgado","year":"2014","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.vaccine.2017.02.048_b0060","doi-asserted-by":"crossref","first-page":"e41756","DOI":"10.1371\/journal.pone.0041756","article-title":"Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes","volume":"7","author":"Faustman","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.02.048_b0065","unstructured":"World Health rganization. Meeting of the trategic Advisory roup of perts on immunization April 0 \u2013- conclusions and recommendations. elev pid miologi ue Hebd \/ ect d\u2019hygi ne du ecr tariat la oci t des ations = Wkly Epidemiol Rec\/Heal Sect Secr Leag Nations [Internet] 2014;89(21):221\u201336. Available from: <http:\/\/www.who.int\/wer\/2014\/wer8921.pdf?ua=1>."},{"issue":"9","key":"10.1016\/j.vaccine.2017.02.048_b0070","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.it.2013.04.004","article-title":"A small jab - a big effect: nonspecific immunomodulation by vaccines","volume":"34","author":"Benn","year":"2013","journal-title":"Trends Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.02.048_b0075","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000355628","article-title":"Long-lasting effects of BCG vaccination on both heterologous Th1\/Th17 responses and innate trained immunity","volume":"6","author":"Kleinnijenhuis","year":"2014","journal-title":"J Innate Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2017.02.048_b0080","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4049\/jimmunol.168.2.919","article-title":"Influence of Mycobacterium bovis bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination","volume":"168","author":"Ota","year":"2002","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2017.02.048_b0085","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/infdis\/jiu508","article-title":"Heterologous immunological effects of early BCG vaccination in low-birth-weight infants in Guinea-Bissau: a randomized-controlled trial","volume":"211","author":"Jensen","year":"2015","journal-title":"J Infect Dis"},{"issue":"43","key":"10.1016\/j.vaccine.2017.02.048_b0090","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2017.02.048_b0095","first-page":"2885","article-title":"Non-specific effect of Bacille Calmette-Gu\u00e9rin vaccine on the immune response to routine immunisations","author":"Ritz","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.048_b0100","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cct.2015.04.006","article-title":"Bacillus Calmette-Gu\u00e9rin immunisation at birth and morbidity among Danish children: A prospective, randomised, clinical trial","volume":"42","author":"Th\u00f8stesen","year":"2015","journal-title":"Contemp Clin Trials"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2017.02.048_b0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jim.2008.02.018","article-title":"Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus","volume":"335","author":"van Gageldonk","year":"2008","journal-title":"J Immunol Methods"},{"issue":"3 Pt 2","key":"10.1016\/j.vaccine.2017.02.048_b0110","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1542\/peds.96.3.548","article-title":"Comparison of 13 acellular pertussis vaccines: overview and serologic response","volume":"96","author":"Edwards","year":"1995","journal-title":"Pediatrics"},{"issue":"3 Pt 2","key":"10.1016\/j.vaccine.2017.02.048_b0115","first-page":"570","article-title":"Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines","volume":"96","author":"Meade","year":"1995","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2017.02.048_b0120","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1128\/CVI.00364-08","article-title":"Simultaneous detection of Haemophilus influenzae type b polysaccharide-specific antibodies and Neisseria meningitidis serogroup A, C, Y, and W-135 polysaccharide-specific antibodies in a fluorescent-bead-based multiplex immunoassay","volume":"16","author":"de Voer","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2017.02.048_b0125","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1128\/CVI.00408-09","article-title":"Optimization and application of a multiplex bead-based assay to quantify serotype-specific IgG against Streptococcus pneumoniae polysaccharides: response to the booster vaccine after immunization with the pneumococcal 7-valent conjugate vaccine","volume":"17","author":"Elberse","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"8865","key":"10.1016\/j.vaccine.2017.02.048_b0130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0140-6736(93)92298-8","article-title":"Antibody response to accelerated immunisation with diphtheria, tetanus, pertussis vaccine","volume":"342","author":"Ramsay","year":"1993","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2017.02.048_b0135","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1745-6215-15-126","article-title":"Disappointment and adherence among parents of newborns allocated to the control group: a qualitative study of a randomized clinical trial","volume":"15","author":"Meinich Petersen","year":"2014","journal-title":"Trials"},{"issue":"5","key":"10.1016\/j.vaccine.2017.02.048_b0140","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1574-6976.2008.00118.x","article-title":"Influence of BCG vaccine strain on the immune response and protection against tuberculosis","volume":"32","author":"Ritz","year":"2008","journal-title":"FEMS Microbiol Rev"},{"issue":"SUPPL. 1","key":"10.1016\/j.vaccine.2017.02.048_b0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jcpa.2007.04.008","article-title":"Immune responsiveness in the neonatal period","volume":"137","author":"Morein","year":"2007","journal-title":"J Comp Pathol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.02.048_b0150","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1203\/01.pdr.0000228319.10481.ea","article-title":"Innate immunity of the human newborn is polarized toward a high ratio of IL-6\/TNF-alpha production in vitro and in vivo","volume":"60","author":"Angelone","year":"2006","journal-title":"Pediatr Res"},{"issue":"5 Pt 2","key":"10.1016\/j.vaccine.2017.02.048_b0155","doi-asserted-by":"crossref","first-page":"98R","DOI":"10.1203\/PDR.0b013e31819f195d","article-title":"Developmental biology of the innate immune response: implications for neonatal and infant vaccine development","volume":"65","author":"Philbin","year":"2009","journal-title":"Pediatr Res"},{"issue":"5","key":"10.1016\/j.vaccine.2017.02.048_b0160","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nri2075","article-title":"Innate immunity of the newborn: basic mechanisms and clinical correlates","volume":"7","author":"Levy","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2017.02.048_b0165","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0b013e3181faa6be","article-title":"Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a 15 double-blind randomized active-controlled trial.","volume":"29","author":"Snape","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.vaccine.2017.02.048_b0170","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/jama.2013.228052","article-title":"Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial","volume":"310","author":"Spijkerman","year":"2013","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.vaccine.2017.02.048_b0175","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1128\/CVI.00414-13","article-title":"Randomized, controlled, multicenter study of the immunogenicity and safety of a fully liquid combination diphtheria-tetanus toxoid-five-component acellular pertussis (DTaP5), inactivated poliovirus (IPV), and Haemophilus influenzae type b (Hib) vaccine co","volume":"20","author":"Vesikari","year":"2013","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.02.048_b0180","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/INF.0b013e3182717edf","article-title":"Safety and immunogenicity of a hexavalent vaccine administered at 2, 4 and 6 months of age with or without a heptavalent pneumococcal conjugate vaccine: a randomized, open-label study","volume":"32","author":"Tapi\u00e9ro","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.02.048_b0185","first-page":"1","article-title":"The immunological basis for immunization series \u2013 Module 2: Diphtheria Update","volume":"2009","author":"Scheifele","year":"2009","journal-title":"World Heal Orig"},{"issue":"5","key":"10.1016\/j.vaccine.2017.02.048_b0190","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1473-3099(10)70049-9","article-title":"The Xs and Y of immune responses to viral vaccines","volume":"10","author":"Klein","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2017.02.048_b0195","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1073\/pnas.1321060111","article-title":"Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination","volume":"111","author":"Furman","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.vaccine.2017.02.048_b0200","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1128\/CVI.00123-08","article-title":"Gender-dependent HLA-DR-restricted epitopes identified from herpes simplex virus type 1 glycoprotein D","volume":"15","author":"Zhang","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.02.048_b0205","doi-asserted-by":"crossref","DOI":"10.1089\/vim.2011.0051","article-title":"Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination","volume":"25","author":"Umlauf","year":"2012","journal-title":"Viral Immunol"},{"issue":"49","key":"10.1016\/j.vaccine.2017.02.048_b0210","doi-asserted-by":"crossref","first-page":"9246","DOI":"10.1016\/j.vaccine.2011.09.110","article-title":"Antibody responses and cross protection against lethal influenza A viruses differ between the sexes in C57BL\/6 mice","volume":"29","author":"Lorenzo","year":"2011","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2017.02.048_b0215","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nri2394","article-title":"The X-files in immunity: sex-based differences predispose immune responses","volume":"8","author":"Fish","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2017.02.048_b0220","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/01.ede.0000231546.14749.ab","article-title":"Tuberculin reaction, BCG scar, and lower female mortality","volume":"17","author":"Roth","year":"2006","journal-title":"Epidemiology"},{"issue":"8","key":"10.1016\/j.vaccine.2017.02.048_b0225","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/01.inf.0000227829.64686.ae","article-title":"Sex differential effects of routine immunizations and childhood survival in rural Malawi","volume":"25","author":"Aaby","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.02.048_b0230","first-page":"jiv332","article-title":"BCG vaccination enhances the immunogenicity of subsequent influenza vaccination in healthy volunteers: a randomized, placebo-controlled pilot study","volume":"212","author":"Leentjens","year":"2012","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17302517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17302517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T00:23:12Z","timestamp":1719102192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17302517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":46,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0264410X17302517"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.048","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacille Calmette-Gu\u00e9rin (BCG) vaccination at birth and antibody responses to childhood vaccines. A randomised clinical trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}